| Accession Number | 0001763554-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 19, 2026 |
| Document Date | Feb 17, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP, CEO--Health & Wellness | Dividend Equivalent Unit | โ | Feb 17, 2026 | Grant/Award | 208 | $72.31 | $15,040.48 | 93,058 | Direct | โ | View Details | |
EVP, CEO--Health & Wellness | Common Stock | โ | Feb 17, 2026 | Exercise/Conversion | 5,794 | $34.30 | $198,734.20 | 98,852 | Direct | โ | View Details | |
EVP, CEO--Health & Wellness | Common Stock | โ | Feb 17, 2026 | Sale | 41,514 | $70.60 | $2,930,888.40 | 57,338 | Direct | โ | View Details | |
EVP, CEO--Health & Wellness | Phantom Stock Units | Derivative | Feb 17, 2026 | Grant/Award | 1 | $0.00 | $0.00 | 185 | Direct | โ | View Details | |
EVP, CEO--Health & Wellness | Employee Stock Option (right to buy) | Derivative | Feb 17, 2026 | Exercise/Conversion | 5,794 | $0.00 | $0.00 | 5,794 | Direct | โ | View Details |